Introduction
Long-term immunity to viruses is facilitated by the generation and persistence of virus-specific memory T cells. Virus-specific T cells are comprised of both central memory (CM) T cells which are long-lived and provide a continuous source of effector T cells and effector memory (EM) T cells which possess immediate effector functions capable of clearing virus. In human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) the ability to generate and sustain CM and EM CD4 + T cells is impeded by direct infection and killing of memory CD4 + T cells (Groot et al., 2006; Mattapallil et al., 2005; Nishimura et al., 2007; Okoye et al., 2007; Wang et al., 2007) . Although several markers have been used to define CM T cells (Okoye et al., 2007) the combination of monoclonal antibodies (mAbs) CD28 and CD95 effectively discriminates CD4 + naïve and memory T cell subsets in rhesus macaques (Pitcher et al., 2002; Sun et al., 2007) . It was recently reported that preservation of CD28 + CD95 + CM CD4 + T cells during chronic infection is strongly associated with survival but not control of viremia in vaccinated rhesus macaques challenged with SIV (Letvin et al., 2006) . Subsequent studies of unvaccinated SIV-infected rhesus and cynomolgus macaques have shown a positive correlation between loss of CM CD4 + T cells and viral load (Karlsson et al., 2007a; Nishimura et al., 2007; Sun et al., 2007 (Estes et al., 2006) or limit harmful T cell hyperactivation (Legrand et al., 2006) since depletion of Tregs in vitro enhances the ability to detect HIV-specific T cell immunity (Aandahl et al., 2004; Kinter et al., 2004) yet Treg depletion in HIV infection is also associated with immune activation (Eggena et al., 2005) . The comparative role of Tregs and memory T cell subsets in controlling SIV disease progression has not been defined in pigtail macaques. Low surface expression of the IL-7 receptor (CD127) has recently been used to define Tregs that express intracellular FoxP3 + in humans (Liu et al., 2006; Seddiki et al., 2006 Results and discussion
SIV-infected, untreated pigtail macaques have variable disease progression
We examined naïve and memory CD4 + T cell subsets in 12 SIV mac251 -infected pigtail macaques from a recently completed vaccine study (Kent et al., 2008) . Six of the 12 animals were vaccinated with a recombinant Kunjin virus expressing SIV Gag, the other 6 were unvaccinated controls. No vaccine related immune responses were induced and disease progression following challenge with SIV mac251 was identical between the 2 groups (Kent et al., 2008) . As expected, the 12 animals had variable success in controlling SIV replication in the absence of treatment and were grouped into rapid, conventional and slow progressor (RP, CP and SP, respectively) groups based on a composite criteria of survival time and mean set point viral load 5-23 weeks post-infection (p.i.) (Figs. 1a,b and Table 1 ). We identified three SP (5612, 5831 and 6158). Animal 5612 reduced viral load to below the detection threshold (b1500 copies/ mL) while 5831 and 6158 remained healthy with low but detectable viremia. All 3 SP survived more than 1 year following SIV infection.
There were 4 RP (5773, 5807, 6115 and 6267) who were unable to control viral replication and were euthanized with incipient AIDS 16 to 19 weeks post-infection. The remaining 5 animals (3C7D, 3117, Total, baseline and nadir CD4 + T cell counts do not account for different disease progression phenotypes
We first examined whether variable disease outcomes in the 11 untreated pigtail macaques was due to differences in total CD4 + T cells and CD4 subset counts. CD4 + T cell subsets were delineated by flow cytometry in fresh whole blood samples. A gradual depletion of total CD4 + T cells was observed in all animals, but there was no statistical difference between the three groups (nonparametric Mann Whitney ranksum p N 0.4, Fig. 1c ). Group baseline (week 0) total CD4 + T cell counts were not statistically different and nadir CD4 + T cell counts, defined as the lowest measured CD4 + T cell count, were only marginally different between the SP and CP groups (p = 0.04, twotailed t-test) ( Table 1) .
Preservation of central memory CD4 + T cells in SIV-infected pigtail macaques is associated with survival and control of viremia
The lack of a strong association between total CD4 + T cells and disease progression of SIV-infected pigtail macaques, suggested that examining subsets of CD4 + T cells may reveal depletion of memory CD4 + T cells as reported for rhesus and cynomolgus macaques (Karlsson et al., 2007a; Sun et al., 2007) . We therefore examined central memory (CM), effector memory (EM) and naive T cell subsets in serial blood samples pre-and post-infection based on wellvalidated CD28 and CD95 expression patterns (Picker et al., 2004; Pitcher et al., 2002 Tregs in all 11 pigtail macaques [ Fig. 3a ] and is consistent with Treg phenotype observed in rhesus macaques (Hartigan-O'Connor et al., 2007) . We then used this assay to surface stain fresh peripheral blood over the course of SIV infection [ Fig. 3b ]. There was no difference in Treg numbers pre-infection and depletion in total Tregs during the course of SIV infection in all 3 progressor populations. The pattern of rapid decline in Tregs following acute SIV infection with subsequent rebound and then more gradual decline during chronic SIV infection is similar to that reported for Tregs in SIV-infected cynomologus macaques (Karlsson et al., 2007b) . In summary, we evaluated the relationship between memory and Treg subsets of CD4 + T cells with survival and disease progression in SIV-infected pigtail macaques. Preservation of CM CD4 + T cells was associated with survival in pigtail macaques, consistent with previous reports in rhesus macaques (Letvin et al., 2006) . In accordance with previous studies of rhesus and cynomolgus macaques (Karlsson et al., 2007a; Sun et al., 2007) , we observed a significant association between preservation of CM CD4 + T cells and control of viremia in SIV-infected pigtail macaques. Given the strong associations between viral levels and disease outcome, an association between CM CD4 + T cells and VL is not unexpected. Our longitudinal analysis of CM, EM, naïve and Treg CD4 + T cell subsets in 12 treatment naïve SIV-infected pigtail macaques showed an unexpected finding of low baseline CM CD4 + T cells in rapid progressors, but not other CD4 + T cell subsets. Low pre-infection levels of CM CD4 + T cells predicting SIV disease has not been reported in rhesus macaques although it is unclear whether this has been carefully studied in the rhesus-SIV model (Letvin et al., 2006; Okoye et al., 2007) . In our experience pigtail macaques progress more rapidly to AIDS in comparison to rhesus macaques (Batten et al., 2006) . We speculate that the more rapid progression in the pigtail macaque model may make animals with lower pre-infection levels of CM CD4 + T cells more vulnerable to rapid progression in comparison to models with slower disease progression. Further analyses on even larger cohorts of SIV-infected macaques are clearly warranted. Depletion of already low CM CD4 + T cell levels might predispose to disease progression and, if confirmed in larger studies, should be taken into account in randomizing macaques for pathogenesis and vaccine studies.
Materials and methods

Animals and viruses
Twelve SIV mac251 -infected pigtail macaques (M. nemestrina) examined in this study were part of a recently completed failed Kunjin replicon SIV vaccine trial (Kent et al., 2008) approved by the University of Melbourne animal ethics committee. The SIV mac251 (kindly supplied by Drs N. Miller and R. Pal) was injected IV at 40 TCID50. Plasma SIV RNA levels were determined by real-time PCR as previously described (Fernandez et al., 2007) . Prospective criteria for euthanasia for incipient AIDS, agreed with our animal ethics committee, were weight loss (N10%), loss of appetite, persistently reduced activity, chronic diarrhoea, or clinical disease consistent with infection or malignancy.
Phenotyping of CD4 + T cell subsets
Staining of CD4 + T cell subsets was performed on fresh whole blood collected in sodium heparin vacuette tubes. 250 μl of whole blood was stained for 1 h at room temperature with a monoclonal antibody cocktail containing either i) anti-CD3 allophycocyanin (APC) clone SP34-2, anti-CD4 phycoerythrin-Cy7 (PE-Cy7) clone SK3, anti-CD28 
